Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation

Role of Peroxiredoxin I in Rectal Cancer and Related to p53 Status

(2010) Miao-Fen Chen et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Peroxiredoxins, a novel target in cancer radiotherapy

(2009) Bo Zhang et al.   CANCER LETTERS

Novel Protective Mechanism against Irreversible Hyperoxidation of Peroxiredoxin

(2009) Jae Ho Seo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Association of reactive oxygen species levels and radioresistance in cancer stem cells

(2009) Maximilian Diehn et al.   NATURE

Esophageal cancer: current and emerging therapy modalities

(2008) Simon Ekman et al.   Expert Review of Anticancer Therapy

A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway

(2008) So Yong Kim et al.   FEBS LETTERS

Irreversible Oxidation of the Active-site Cysteine of Peroxiredoxin to Cysteine Sulfonic Acid for Enhanced Molecular Chaperone Activity

(2008) Jung Chae Lim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

PrP mutants with different numbers of octarepeat sequences are more susceptible to the oxidative stress

(2008) Run An et al.   Science in China. Series C, Life sciences / Chinese Academy of Sciences

Nonclassical secretion of human catalase on the surface of CHO cells is more efficient than classical secretion

(2007) Zuyong He et al.   CELL BIOLOGY INTERNATIONAL